Host Adaptation of a Bacterial Toxin from the Human Pathogen Salmonella Typhi  by Deng, Lingquan et al.
ArticleHost Adaptation of a Bacterial Toxin
from the Human Pathogen Salmonella Typhi
Lingquan Deng,1,2,4,8 Jeongmin Song,5,8,9 Xiang Gao,5,8 Jiawei Wang,6 Hai Yu,7 Xi Chen,7 Nissi Varki,1,3
Yuko Naito-Matsui,1,2,4 Jorge E. Gala´n,5,* and Ajit Varki1,2,3,4,*
1Glycobiology Research and Training Center
2Department of Medicine
3Department of Pathology
4Department of Cellular and Molecular Medicine
University of California, San Diego, La Jolla, CA 92093, USA
5Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT 06536, USA
6School of Life Sciences, Tsinghua University, Beijing 100084, PRC
7Department of Chemistry, University of California, Davis, Davis, CA 95616, USA
8Co-first author
9Present address: Department of Microbiology and Immunology, Cornell University College of Veterinary Medicine, Ithaca, NY 14853, USA
*Correspondence: jorge.galan@yale.edu (J.E.G.), a1varki@ucsd.edu (A.V.)
http://dx.doi.org/10.1016/j.cell.2014.10.057SUMMARY
Salmonella Typhi is an exclusive human pathogen
that causes typhoid fever. Typhoid toxin is a S. Typhi
virulence factor that can reproduce most of the
typhoid fever symptoms in experimental animals.
Toxicity depends on toxin binding to terminally sialy-
lated glycans on surface glycoproteins. Human gly-
cans are unusual because of the lack of CMAH,which
in other mammals converts N-acetylneuraminic acid
(Neu5Ac) to N-glycolylneuraminic acid (Neu5Gc).
Here, we report that typhoid toxin binds to and is
toxic toward cells expressing glycans terminated in
Neu5Ac (expressed by humans) over glycans termi-
nated in Neu5Gc (expressed by other mammals).
Mice constitutively expressing CMAH thus display-
ing Neu5Gc in all tissues are resistant to typhoid
toxin. The atomic structure of typhoid toxin bound
to Neu5Ac reveals the structural bases for its binding
specificity. These findings provide insight into the
molecular bases for Salmonella Typhi’s host speci-
ficity and may help the development of therapies
for typhoid fever.
INTRODUCTION
Salmonella enterica serovar Typhi (S. Typhi), the cause of
typhoid fever, continues to be a major public health concern,
particularly in developing countries. There are more than
20 million cases of typhoid fever every year, which result in
more than 400,000 deaths (Crump and Mintz, 2010; Parry and
Threlfall, 2008; Voetsch et al., 2004). Unlike the illnesses associ-
ated with most other Salmonella, which are usually self-limiting
gastroenteritis (i.e., ‘‘food poisoning’’), typhoid fever is a sys-
temic, often lethal disease (Parry et al., 2002). In addition, in
contrast to most Salmonella enterica serovars, which can infect1290 Cell 159, 1290–1299, December 4, 2014 ª2014 Elsevier Inc.a broad range of hosts, S. Typhi exhibits remarkable host spec-
ificity, causing symptomatic infections only in humans (Ohl and
Miller, 2001; Parry et al., 2002; Raffatellu et al., 2008). The mech-
anisms of S. Typhi host specificity are incompletely understood
and most likely multifactorial. For example, S. Typhi is unable to
replicate in most hosts, except chimpanzees where it was found
to reach levels equivalent to those in humans (Edsall et al., 1960;
Metchnikoff and Besredka, 1911). However, despite significant
bacterial replication, S. Typhi did not cause typical typhoid fever
symptoms in chimpanzees, which developed a milder and much
shorter lasting disease syndrome (Edsall et al., 1960; Metchnik-
off and Besredka, 1911). These observations indicate that in
addition to pathogen restriction, there are other host factors
that must prevent the development of typhoid fever even in the
presence of significant bacterial replication. Host restriction is
manifested at the cellular level because, in contrast to human
macrophages, S. Typhi is unable to survive within macrophages
of nonpermissive species (Schwan et al., 2000; Vladoianu et al.,
1990). Recent studies have identified a Rab32-dependent path-
ogen-restriction mechanism that limits the growth of S. Typhi
within macrophages of nonpermissive species (Spano` and
Gala´n, 2012). In contrast, this antimicrobial function is effectively
neutralized by broad-host Salmonella serovars, which are able to
proteolytically target Rab32 with a type III secretion effector pro-
tein that is absent from S. Typhi (Spano` and Gala´n, 2012; Spano`
et al., 2011).
Typhoidal (i.e., able to cause typhoid fever) Salmonella sero-
vars (e.g., S. Typhi and S. Paratyphi) encode typhoid toxin, a
unique member of the AB5 exotoxin family (Haghjoo and Gala´n,
2004; Song et al., 2013; Spano` et al., 2008). Unlike all known
members of this family, which possess a single enzymatic A sub-
unit associated to a pentameric B subunit (Beddoe et al., 2010),
typhoid toxin is composed of two covalently linked enzymatic
subunits, the deoxyribonuclease CdtB and the ADP ribosyl
transferase PltA, associated to the homopentameric B subunit
PltB (Song et al., 2013). Thus typhoid toxin may have evolved
from the combination of two exotoxins, cytolethal distending
and pertussis toxins, and is the only known example of a toxin
Figure 1. Comparison of Typhoid Toxin
Binding to Paired Neu5Ac- and Neu5Gc-
Terminated Glycans by a Customized
Microarray
Chemical structures of Neu5Ac and Neu5Gc are
shown. The twomolecules differ by only one single
oxygen atom. Vertical axis values represent the
normalized average of relative fluorescence units
and horizontal axis indicates the glycan number in
the array.
See also Figure S1 and Tables 1 and S1.with an A2B5 organization. Recent studies have shown that direct
injection of typhoid toxin into experimental animals can repro-
duce many of the pathognomonic symptoms of typhoid fever,
thus placing this toxin at the center of the pathogenesis of this
devastating disease (Song et al., 2013).
To enter cells typhoid toxin must bind glycosylated surface
glycoprotein receptors in target cells, such as podocalyxin 1 on
epithelial cells and CD45 on myelocytic cells (Song et al., 2013).
The toxin recognizes specific sialylatedglycanmoieties on the re-
ceptor proteins through a glycan-binding domain in its PltB B
subunit. Sialoglycans on human cells are unusual in that they
are primarily terminated in N-acetylneuraminic acid (Neu5Ac)
(Varki et al., 2011). This is in contrast to other old world primates
and most other mammals studied to date, whose glycans can
also terminate in N-glycolylneuraminic acid (Neu5Gc). These dif-
ferences in glycan composition are the result of the absence of
CMP-N-acetylneuraminic acid hydroxylase (CMAH) in humans,
due to an Alu-mediated exon deletion in the CMAH gene, which
occurred after the separation of the Hominin lineage from other
Hominids (the so-called ‘‘great apes,’’ e.g., chimpanzees)
(Chou et al., 2002). Here, we report that typhoid toxin exhibits
exquisite specificity for human-like Neu5Ac-terminated glycans.
We find that typhoid toxin is cytotoxic to cells expressingNeu5Ac
glycans on their surface but not to those expressing Neu5Gc.
Furthermore, typhoid toxin binds strongly to human tissues but
poorly to those from chimpanzees, which predominantly display
Neu5Gc-terminated glycans and do not develop the typical
symptoms of typhoid fever. We also show that mice engineered
to display Neu5Gc glycans in all tissues are resistant to typhoid
toxin. These findings provide major insight into the molecular
bases for the host specificity of S. Typhi and may help the devel-
opment of novel therapeutic approaches against typhoid fever.
RESULTS
Typhoid Toxin Exhibits Strong Specificity
for Neu5Ac-Terminated Glycans
Given the remarkable human specificity exhibited by S. Typhi
and the central role of typhoid toxin in the pathogenesis ofCell 159, 1290–1299, Dtyphoid fever, we used a customized
glycan array (Padler-Karavani et al.,
2014) to compare the ability of fluores-
cently labeled typhoid toxin to bind pairs
of sialylated glycans terminated in either
Neu5Ac (predominantly expressed in hu-man cells) or Neu5Gc (predominantly expressed in cells of most
other mammals). Consistent with previous results (Song et al.,
2013), typhoid toxin bound a diverse group of sialylated glycans
with preferential binding to termini with the consensus sequence
Neu5Aca2-3Galb1-3/b1-4Glc/GlcNAc (Figure 1; Table 1; Table
S1 available online). Remarkably, however, we found that
typhoid toxin did not bind to otherwise identical glycans termi-
nated in Neu5Gc (i.e., differing by a single oxygen atom) (Fig-
ures 1 and S1; Table 1; Table S1). Themarked difference in bind-
ing was observed across all the glycans tested and with different
toxin concentrations (Table 1; Figure S1; Table S1). Consistent
with previous observations (Song et al., 2013), typhoid toxin car-
rying a mutation in the glycan-binding site of its PltB B subunit
(PltBS35A) did not show significant binding to any of the glycans
tested regardless of their sialylation status (Table S1). To confirm
typhoid toxin’s preference for Neu5Ac-terminated glycans, we
compared its binding to human and chimpanzee red blood cells,
which display markedly different levels of surface Neu5Ac or
Neu5Gc-terminated glycans (Figure 2A). In keeping with the
glycan array findings, typhoid toxin showedmuch stronger bind-
ing to human than to chimpanzee cells (Figure 2B). Furthermore,
the differences were observed at different toxin concentrations
(Figure 2B). Similar differences were observed with lymphocytes
from humans and chimpanzees (Figures 2C and 2D). These re-
sults indicate that typhoid toxin exhibits strong binding prefer-
ence for Neu5Ac-terminated glycans, which are predominant
in human cells.
Incorporation of Neu5Gc Renders Human Cells
Resistant to Typhoid Toxin
Although human cells lack Neu5Gc, they can metabolically
incorporate this sialic acid if supplied into the cell culturemedium
(Tangvoranuntakul et al., 2003). To investigate the biological sig-
nificance of typhoid toxin glycan selectivity, we compared the
binding of fluorescently labeled typhoid toxin to human Henle-
407 epithelial cells that had been grown in media supplemented
with Neu5Gc or Neu5Ac. Predictably, growth in the presence of
Neu5Gc significantly altered the sialic acid composition in these
cells resulting in up to 60% of the total sialic acid containingecember 4, 2014 ª2014 Elsevier Inc. 1291
Table 1. Analysis of Fine Ligand Specificity of Native Typhoid
Toxin by a Customized Sialoglycan Microarray
Glycan Structure
Mean Relative
Fluorescence
Units (n = 4)
Sia =
Neu5Ac
Sia =
Neu5Gc
Siaa3Galb3GlcNAcb3Galb4GlcbO(CH2)3NH2 34,441 25
Sia9Aca3Galb3GlcNAcbO(CH2)3NH2 23,120 73
Siaa3Galb3GlcNAcbO(CH2)3NH2 20,664 156
Siaa3Galb3GalNAcaO(CH2)3NH2 17,100 88
Siaa8Siaa3Galb4GlcbO(CH2)3NH2 15,821 134
Siaa3Galb4GlcbO(CH2)3NH2 14,781 108
Sia9Aca3Galb3GalNAcaO(CH2)3NH2 13,299 42
Siaa3Galb3GalNAcbO(CH2)3NH2 12,564 147
Siaa3Galb4GlcNAcbO(CH2)3NH2 10,468 114
Sia9Aca3Galb4GlcNAcbO(CH2)3NH2 10,076 30
Siaa6Galb4GlcbO(CH2)3NH2 9,605 79
Sia9Aca3Galb3GalNAcbO(CH2)3NH2 8,993 72
Siaa3(Neu5Aca6)Galb4GlcbO(CH2)3NH2 8,205 246
Sia9Aca3Galb4GlcbO(CH2)3NH2 6,730 76
Sia9Aca6Galb4GlcbO(CH2)3NH2 6,619 56
Sia9Aca3GalbO(CH2)3NH2 3,513 152
Siaa3GalbO(CH2)3NH2 3,040 182
Sia9Aca6Galb4GlcNAcbO(CH2)3NH2 2,160 89
Siaa6GalbO(CH2)3NH2 2,078 125
Siaa6Galb4GlcNAcbO(CH2)3NH2 1,979 229
Siaa3Galb4(Fuca3)GlcNAcbO(CH2)3NH2 1,633 51
Siaa3Galb4(Fuca3)GlcNAc6SbO(CH2)3NH2 827 96
Sia9Aca6GalbO(CH2)3NH2 592 133
Siaa3Galb4GlcNAc6SbO(CH2)3NH2 511 80
Siaa6GalNAcaO(CH2)3NH2 470 200
Sia9Aca6GalNAcaO(CH2)3NH2 217 49Neu5Gc (Figure 3A). In contrast, cells grown in standardmedia or
supplemented with Neu5Ac had almost undetectable levels of
Neu5Gc (Figure 3A). Consistent with its reduced binding affinity
to Neu5Gc terminated glycans, typhoid toxin binding and toxicity
was markedly reduced in cells grown in the presence of Neu5Gc
(Figures 3B–3D and S2). In contrast, levels of toxin binding and
cytotoxicity were slightly increased in cells grown in media sup-
plemented with Neu5Ac in comparison to cells grown in stan-
dard media (Figures 3B–3D and S2). Equivalent results were
observed in Jurkat T cells, which display a different glycoprotein
receptor for typhoid toxin (Song et al., 2013) (Figures 3E–3H).
These results indicate that the abundance of Neu5Gc on the sur-
face glycans render cells less permissive for toxin binding and
therefore resistant to typhoid toxin.
Constitutive Expression of Neu5Gc Renders Mice
Resistant to Typhoid Toxin
Although wild-type mice express a fully functional CMAH and
can express Neu5Gc, most of their tissues contain a significant
amount of Neu5Ac as well, presumably due to low expression1292 Cell 159, 1290–1299, December 4, 2014 ª2014 Elsevier Inc.of CMAH in some cells (Hedlund et al., 2007). Consistent with
this observation, Cmah/ mice (Hedlund et al., 2007) did not
exhibit significantly higher susceptibility to typhoid toxin,
showing equivalent levels of weight loss, white blood cell deple-
tion, and time to death compared to those observed in wild-type
animals (Figures 4A–4D). In fact, these mice exhibited a slightly
reduced susceptibility to the toxin, which is most likely due to
the presence of high levels of Neu5Ac-containing glycoproteins
in the sera of these animals, which may provide protection
against toxicity by competing with toxin binding to tissue recep-
tors (Beddoe et al., 2010). We therefore tested the susceptibility
to typhoid toxin of mice engineered to constitutively overexpress
CMAH in all tissues (Cmahtg) (Figures 4A–4D). We reasoned that
the forced expression of CMAH would result in the predominant
display of Neu5Gc on the surface of all cells and thus confer pro-
tection against intoxication. Consistent with this hypothesis,
Cmahtg mice were completely resistant to systemic administra-
tion of toxin amountsmuch higher than those that would be lethal
for wild-type mice (Figure 4D). Also consistent with these obser-
vations, the binding of fluorescently labeled typhoid toxin was
undetectable in tissues fromCmahtgmice butwas readily detect-
able in tissues from wild-type and Cmah/mice (Figure S3).
Typhoid Toxin Does Not Bind to Chimpanzee Tissues
Previous studies have shown that chimpanzees can be experi-
mentally infected with S. Typhi (Edsall et al., 1960; Metchnikoff
and Besredka, 1911). However, infected animals did not develop
the typical symptomatology associated with typhoid fever, such
as the presence of stupor and extreme lethargy, showing instead
a course of disease that was mild and brief. We found that, con-
trary to human tissues, toxin binding to chimpanzee organ tissue
sections was nondetectable (Figure 5). This is explained by the
observation that chimpanzee cells predominantly display
Neu5Gc-terminated glycans on their surface and are therefore
not permissive for toxin binding. These results are consistent
with the hypothesis that the lack of pathognomonic typhoid fever
symptomatology observed in chimpanzees experimentally in-
fected with S. Typhi is due to the inability of typhoid toxin to
gain access to target cells.
The Crystal Structure of Typhoid Toxin B Subunit PltB
Bound to Its Sialic Acid Ligand Reveals Structural Bases
for Its Binding Specificity
To gain insight into the structural bases for typhoid toxin’s bind-
ing specificity, we determined the atomic structure at 1.92 A˚ res-
olution of PltB bound to GalNAcb1-4(Neu5Aca2-8Neu5Aca2-3)
Galb1-4Glc (Figures 6A and 6B; Table S2), which previous
studies have shown binds typhoid toxin with high affinity (Song
et al., 2013). Clear electron density corresponding to the
(Neu5Aca2-8Neu5Aca2-3)Gal trisaccharide was unambiguously
observed at the canonical glycan-binding sites in two of the five
subunits of the PltB pentamer (Figures 6A–6C). Because the
glycan-binding sites of every subunit are identical, absence of
binding to some subunits is most likely due to their limited
accessibility because of crystal packing. No specific contacts
between the galactose moiety and PltB were observed in the
structure (Figure S4). In contrast, the first of the twoNeu5Acmoi-
eties interacts through multiple direct hydrogen bonds and
Figure 2. Typhoid Toxin Binding to Red
Blood Cells and Lymphocytes fromHumans
and Chimpanzees
(A) Relative levels of Neu5Ac/Neu5Gc in human
and chimpanzee red blood cells (RBCs).
(B) Binding of different amounts of typhoid toxin to
human and chimpanzee RBCs.
(C) Relative levels of Neu5Ac/Neu5Gc in human
and chimpanzee lymphocytes.
(D) Binding of typhoid toxin to human and chim-
panzee lymphocytes. Similar results were ob-
tained in several independent repetitions of the
experiments. RFI, relative fluorescence intensity.
PBS, phosphate buffered saline.water-mediated hydrogen bonds with Tyr33, Ser35, Lys59,
Thr65, and Arg100 in PltB (Figure 6D). In addition, the first
Neu5Ac sugar ring makes hydrophobic contacts with the aro-
matic rings of Tyr33 and Tyr34. The second Neu5Ac contacts
PltB through direct and water-mediated hydrogen bonds with
Ser35, Asp36, Lys59, Asn61, Ser63, Ala130, and Thr131 of the
glycan-binding domain (Figure S4). Consistent with their impor-
tance in carbohydrate binding, mutations in Tyr33, Ser35, and
Lys59 drastically disrupted typhoid toxin activity (Figures 6E
and S5). Some toxin B subunits undergo conformational
changes upon binding their glycan receptors (Sixma et al.,
1992). To investigate this possibility, we solved the atomic struc-
ture of the apo form of PltB at 2.08 A˚ resolution. Comparison of
the atomic structures of the receptor-bound and apo forms of
PltB indicates that binding to glycan receptors does not result
in marked conformational changes in PltB (Figure S6).
Typhoid toxin’s PltB shares its oligosaccharide-binding fold
with the B subunits of other AB5 toxins such as subtilase cyto-
toxin’s SubB (Byres et al., 2008; Song et al., 2013). However,
SubB exhibits the opposite specificity, strongly favoring binding
to Neu5Gc-terminated glycans (Byres et al., 2008). Therefore,
comparison of the atomic structures of PltB and SubB bound to
their glycan receptors afforded usanopportunity to obtain insight
into the structural bases for the binding specificity. The arrange-
ment of themain chain ofNeu5Ac relative to thebinding pocket of
PltB is very similar to that of Neu5Gc bound to SubB (Byres et al.,
2008), and many of the critical interactions between the glycans
and specific residues of PltB andSubBare conserved (Figure 6F).
However, a residue equivalent to Tyr78 in SubB, which forms a
critical hydrogen bond with the extra hydroxyl group in Neu5Gc
is missing from PltB (Figure 6F). Instead, at this position PltB
has the nonpolar residue Val103 and thus is unable to interact
with Neu5Gc. These findings provide a structural explanation
for typhoid toxin’s inability to bind Neu5Gc-terminated glycansCell 159, 1290–1299, Dand suggest an evolutionary pathway by
which this toxin restricted its binding to
human-specific glycans.
DISCUSSION
Unlike most other Salmonella enterica se-
rovars, which can infect a broad range of
hosts, S. Typhi can only infect humans, inwhom it causes typhoid fever, a severe, often lethal disease. The
process by which S. Typhi has lost its ability to explore other
niches and evolved to cause disease only in humans is incom-
pletely understood and likely to be multifactorial (Jacobsen
et al., 2011; Sabbagh et al., 2010). The S. Typhi genome
sequence exhibits an unusually high number of pseudogenes,
suggesting that genome reduction most likely played a central
role in its adaptation to a single host (Parkhill et al., 2001). For
example, the interaction of Salmonella enterica with host cells
is largely dictated by two type III secretion systems (T3SS),
which deliver bacterial effector proteins into host cells to modu-
late cellular functions (Gala´n, 2001; Ibarra and Steele-Mortimer,
2009; Srikanth et al., 2011; Waterman and Holden, 2003).
Although these systems are highly conserved across different
Salmonella serovars, the effectors they deliver are not, and
S. Typhi expresses a significantly smaller number of effector pro-
teins thanmost other serovars. One of themissing effectors from
S. Typhi is GtgE, which is involved in neutralizing a host restric-
tion pathway that prevents its growth inmacrophages of nonper-
missive species (Spano` et al., 2011).
S. Typhi host specificity, however, is not exclusively due to its
inability to replicate within nonpermissive hosts. For example,
unlike mice, chimpanzees were found to be permissive for
S. Typhi replication, and experimental infections showed that
in these animals it reached levels equivalent to those observed
in infected humans (Edsall et al., 1960; Metchnikoff and Bes-
redka, 1911). However, chimpanzees did not develop the typical
symptomatology of typhoid fever indicating that factors other
than pathogen restriction contribute to S. Typhi’s host speci-
ficity. Previous studies have shown that typhoid toxin is central
for the development of pathognomonic symptoms of typhoid fe-
ver (Song et al., 2013). We have shown here that typhoid toxin
exhibits strong selectivity for Neu5Ac-terminated glycans, pre-
dominantly expressed in human cells, over Neu5Gc-terminatedecember 4, 2014 ª2014 Elsevier Inc. 1293
Figure 3. Typhoid Toxin Binds to and Is
Cytotoxic toward Cells Displaying Neu5Ac-,
But Not to Those Displaying Neu5Gc-,
Terminated Glycans
Human intestinal epithelial Henle-407 cells (A–D)
and human T lymphocyte Jurkat cells (E–H) were
left untreated (medium only) or fed Neu5Ac or
Neu5Gc in a culture medium for 4 days. Cells were
then analyzed by HPLC to examine their relative
sialic acid composition (A andE), or used in typhoid
toxin binding (B and F) and toxicity assays by
examining the cell cycle profile of toxin-treated
cells (C, D, G, and H). Data in (D) and (H) are the
mean ± SEM; ***p < 0.0001, compared to the
percent of control (medium-treated) cells in G2/M
in the same group.
See also Figure S2.glycans, which are predominantly expressed by most other
mammals. Therefore, the exquisite binding selectivity of typhoid
toxin for glycans predominantly expressed in human cells pro-
vides an explanation for the inability of S. Typhi to cause typhoid
fever in some nonpermissive species like chimpanzees, which
allow significant bacterial replication.
The extreme specificity for human glycans exhibited by
typhoid toxin is striking and unprecedented among bacterial
toxins. The bacterial toxin subtilase, expressed by some strains
of E. coli, exhibits the opposite specificity and its B subunit
strongly favors binding to Neu5Gc-terminated glycans (Byres
et al., 2008), which is consistent with the broad host specificity
of this pathogen. Comparison of the crystal structures of subti-1294 Cell 159, 1290–1299, December 4, 2014 ª2014 Elsevier Inc.lase B subunit SubB bound to Neu5Gc
with the structure of PltB bound to
Neu5Ac revealed that the arrangement
of the main chain of the two glycans rela-
tive to their binding pockets is very similar
and many of the critical interactions be-
tween the glycans and specific residues
of PltB and SubB are highly conserved.
However, PltB lacks a residue equivalent
to Tyr78 in SubB, which forms a critical
hydrogen bond with the extra hydroxyl
group in Neu5Gc. Because in all likeli-
hood PltB evolved from a Neu5Gc-bind-
ing ancestor, this finding suggests that
only subtle changes in the glycan-binding
site would have been necessary to drasti-
cally change typhoid toxin’s binding
specificity and host range. However,
mutagenesis analysis of PltB suggests a
more complex picture since changing
Val103 to Tyr in PltB (equivalent to Tyr78
in SubB) resulted in a loss of function
rather than in a change in binding speci-
ficity (Figure S7). Additional structures of
PltB bound to different glycans will be
required to fully understand the evolution
of typhoid toxin’s exquisite binding spec-ificity. Nevertheless, from the host perspective, it is remarkable
that a single oxygen atom could have such a dramatic impact
on pathogenicity.
We have shown here that a toxin produced by a human-
specific pathogen has evolved to selectively bind human sialo-
glycans. This is a remarkable example of virulence factor adap-
tation to a specific host that provides major insight into the
process of host adaptation of the human pathogen S. Typhi.
Given typhoid toxin’s central role in the development of typhoid
fever, these observations provide the bases for novel therapeu-
tic strategies and may help the development of an animal
model for the study of typhoid fever and the pathogenesis of
typhoid toxin.
Figure 4. Mice Engineered to Constitutively Express CMAH, Resulting in Elevated Levels of Neu5Gc in All Tissues, Are Resistant to Typhoid
Toxin
Purified preparations of wild-type typhoid toxin or a binding-defective mutant (PltBS35A) were systemically administered into mice defective in (Cmah/) or
constitutively expressing CMAH (Cmahtg) or control (C57BL/6) mice.
(A–C) Four days after treatment their total weight (A) and the total number of white cells (WBC) (B, top panel) or neutrophils (B, bottom) were measured as
indicated in Experimental Procedures. Black circles represent the percentage of the weight of an animal relative to its weight immediately before treatment
(A). Circulating white blood cells were counted in a hematology analyzer (B). Alternatively, peripheral blood cells from animals that had received the indicated
treatments were stained with an antibody directed to the neutrophil cell marker Gr1 and the number of stained cells was determined by flow cytometry (C).
The histograms shown are from ungated samples. Similar results were obtained in several independent repetitions of the experiment. RFI, relative fluo-
rescence intensity. TT, typhoid toxin. WT, wild-type. Data in (B) are the mean ± SEM; ***p < 0.0001, **p < 0.002 (relative to the buffer control in the same
group).
(D) Survival of mice after administration of different amounts of typhoid toxin. PBS, phosphate buffered saline. The difference in the survival curves of PBS versus
toxin-treated (all concentrations) control and Cmah/ animals was statistically significant (p < 0.001; log-rank Mantel-Cox test). The difference between the
survival curves in control and Cmah/mice after administration of 2 mg of toxin was statistically significant (p < 0.001). However, after administration of 10 mg of
toxin the difference between the survival curves in control and Cmah/ mice was not statistically significant (p < 0.6).
See also Figure S3.
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Figure 5. Typhoid Toxin Does Not Bind to Chimpanzee Tissues
Frozen sections of small intestine from humans or chimpanzeeswere stainedwith fluorescently labeled typhoid toxin or its binding-defective PltBS35Amutant (red)
and counterstained with Hoechst (blue). Scale bar represents 100 mm.EXPERIMENTAL PROCEDURES
Typhoid Toxin Expression and Purification
Expression and purification of typhoid toxin was carried out as previously
described (Song et al., 2013). Plasmids expressing PltB point mutations
were constructed using standard recombinant DNA techniques.
Crystallization
Expression and purification of C-terminal 63 His-tagged PltB used for crystal-
lization have been described previously (Song et al., 2013). Initial spare matrix
crystallization trials of full-length PltB protein preparations (5.5 mg ml1) were
carried out at the Yale University School of Medicine Structural Biology Core
facility. After crystal optimization trials, full-length PltB crystals appeared in 2
to 3 days and matured in 1 week at room temperature using the hanging-
drop vapor-diffusion method in a mix of 1 ml of protein with 1 ml of reservoir
solution consisting of 26% (w/v) PEG1500 and 0.1 M sodium acetate,
pH5.0. Native PltB crystals were soaked by the addition of GD2 in different
concentrations (from 1 mM to 50 mM). In most cases, the crystals broke
upon addition of the sugar, even at sugar concentration of 1 mM. In very few
cases, crystal debris large enough to bemounted on the X-ray sourcewere ob-
tained, which diffracted to 3 A˚.
X-Ray Data Collection and Structure Determination
All data were collected at a wavelength of 1.5418 A˚ on a Rigaku Homelab sys-
tem at the Yale University Chemical and Biophysical Instrumentation Center
(CBIC) (http://cbic.yale.edu). Data were integrated and scaled using the
HKL-2000 package (Otwinowski and Minor, 1997). Further processing was
performed with programs from the CCP4 suite (Collaborative Computational
Project, Number 4, 1994). The apo and GD2 bound PltB structures were
both determined by molecular replacement using PHASER (McCoy et al.,
2007) with the atomic coordinates of chain A of typhoid toxin (Song et al.,
2013) (Protein Data Bank [PDB] ID 4K6L) as the initial search model. To com-
plete the model, manual building was carried out in COOT (Emsley and Cow-
tan, 2004). Figures were prepared using PyMol (DeLano, 2002). The structure
refinement was done by PHENIX (Adams et al., 2010). The data collection and
refinement statistics are summarized in Table S2. Coordinates for the atomic
structures have been deposited in the RCSB Protein Data Bank under PDB
numbers 4RHR and 4RHS.
Alexa 555 Typhoid Toxin Labeling
Purified wild-type and PltBS35A mutant typhoid toxins were fluorescently
labeled with Alexa-555 (Invitrogen) according to the vendor’s recommenda-
tion. Purified typhoid toxin preparations (1 mg/ml in 500 ml of 100mMbicarbon-
ate buffer) were incubated for 1 hr at room temperature (RT) with reactive dye
and applied to a size exclusion chromatography column to separate dye-pro-
tein conjugates from free dye. Degree of labeling was determined by
measuring the absorbance of the conjugate solution at 280 and 555 nm. Effi-
ciency of labeling was equivalent for both wild-type and PltBS35A toxin prepa-
rations (4:1 dye/holotoxin ratio for both preparations). The typhoid holotoxin’s
predicted extinction coefficient is 191,400 M1 cm1.1296 Cell 159, 1290–1299, December 4, 2014 ª2014 Elsevier Inc.Glycan Microarray Analysis
Glycan microarrays were fabricated using epoxide-derivatized glass slides as
previously described (Padler-Karavani et al., 2014). Printed glycan microarray
slides were blocked by ethanolamine, washed and dried, and then fitted in a
multiwell microarray hybridization cassette (ArrayIt) to divide into subarrays.
The subarrays were blocked with Ovalbumin (1% w/v) in PBS (pH 7.4) for
1 hr at RT in a humid chamber with gentle shaking. Subsequently, the blocking
solution was discarded, and diluted wild-type or mutant typhoid toxin samples
(Alexa Fluor 555-labeled) were added to each subarray. After incubating the
toxins for 2 hr at RT with gentle shaking, the slides were extensively washed
to remove nonspecifically bound proteins. The developed glycan microarray
slides were then dried and subjected to scanning by a Genepix 4000B micro-
array scanner (Molecular Devices) immediately. Data analysis was done using
the Genepix Pro 7.0 analysis software (Molecular Devices).
Typhoid Toxin-Sialoglycan Binding Affinity Measured by Microscale
Thermophoresis
The binding affinity of typhoid toxin to different glycans was measured using
microscale thermophoresis as previously described (Wienken et al., 2010).
Briefly, NT-647 fluorescently labeled typhoid toxin was incubated with a
wide range of concentrations (12 mM to 400 mM over 15 2-fold serial dilutions)
of Neu5Aca2-3Galb1-4Glc, at room temperature for 30 min in the dark. After
equilibrium, the mixtures were loaded into 16 hydrophilic glass capillaries
and the microscale thermophoresis analysis was performed using the Mono-
lith NT.115 (Nano Temper). Data were analyzed and binding affinities were
determined by the Nano Temper analysis software package. The sialoglycan
underlying structure, Galb1-4Glc (lactose), was used as a control under the
same conditions.
Mammalian Cell Culture Conditions
Henle-407 human intestinal epithelial and Jurkat human T lymphocyte cells
were cultured in DMEM high glucose + 10% FBS and RPMI1640 + 10%
FBS + 1 mM sodium pyruvate + 10 mM HEPES, respectively. All mammalian
cells were kept at 37C in a cell culture incubator with 5% CO2. Metabolic
incorporate of Neu5Ac or Neu5Gc was carried out as previously described
(Tangvoranuntakul et al., 2003). Briefly, cells were cultured in a standard me-
dium supplemented with 10mMNeu5Ac or 10mMNeu5Gc (Inalco) as follows.
Henle-407 (1.53 104) or Jurkat (13 105) cells were seeded into 12-well culture
plates in 1 ml media with or without 10 mM sialic acid. A stock solution of
50 mM sialic acid was freshly prepared in a DMEM medium whose final pH
was adjusted to neutral with NaOH. During the feeding period, the cells were
continuously monitored and maintained below 80% confluence. After 3 days
of growth, cells were split into 12-well plates at a cell density of 1.5 3 104
(Henle-407) or 1 3 105 (Jurkat) cells per well. The next day the cells were
used for different assays as described below.
High-Performance Liquid Chromatography
High-performance liquid chromatography (HPLC) analysis of sialic acids was
carried out as previously described (Tangvoranuntakul et al., 2003). Briefly,
sialic acids were released from glycans by hydrolysis with acetic acid, filtered
Figure 6. Crystal Structure of Typhoid Toxin
B Subunit PltB Bound to Its Sialic Acid
Ligand
(A) The atomic structure of the PltB pentamer in
complex with the GalNAcb1-4(Neu5Aca2-
8Neu5Aca2-3)Galb1-4Glc oligosaccharide is
shown as a ribbon cartoon with each protomer
depicted in a different color. In the PltB pentamer,
only partial oligosaccharide density (Neu5Ac-
Neu5Ac-Gal) is seen in Chain C (purple) and E
(yellow). Cyan sticks represent the sugar carbon
atoms, blue sticks represent nitrogen atoms, and
red sticks represent oxygen atoms.
(B) Surface charge distribution of the PltB pen-
tamer structure and sugar-binding pockets.
(C) Close-up views of Neu5Ac-Neu5Ac-Gal and its
composite annealed omit difference density map.
PltB chain E and its key residue Ser35 are shown in
yellow. Green mesh represents the sugar differ-
ence density map contoured at 2.5s.
(D) Interactions between PltB and Neu5Ac. Chain
E of PltB is shown as a yellow colored ribbon
cartoon, the amino acids interacting with the sugar
are shown as sticks, and the direct interactions are
shown in black dash. Water is shown as gray balls
and water-mediated interactions are shown as
purple dashes.
(E) Structure/function analysis of the PltB glycan-
binding site. Typhoid holotoxin toxin preparations
containing the indicated PltB mutants were tested
for their ability to intoxicate cultured Henle-407
cells. Toxicity was evaluated by determining the
percentage of cells arrested at the G2/M phase of
the cell cycle, which is a measure of typhoid
toxin’s CdtB activity. Data are the mean ± SEM;
***p < 0.0001, compared to the percent cells
treated with wild-type toxin that are in G2/M.
(F) Comparison of the sugar binding sites of PltB
and SubB bound to Neu5Ac and Neu5Gc,
respectively. Critical residues that differ between
SubB (Tyr78) and PltB (Val103) are highlighted as
sticks. Other interacting amino acids and sugars
are shown in lines. PltB is shown in yellow, Neu5Ac
inCyan,SubB inGreen, andNeu5Gc in light purple.
See also Figures S4, S5, S6, and S7 and Table S2.through a 10K Microcon filter unit (Millipore) and then derivatized by 1,2-dia-
mino-4,5-methylene dioxybenzene (DMB) at 50C for 2.5 hr in the dark. Result-
ing samples were analyzed by HPLC using a C18-column.
Typhoid Toxin Binding Assay
Cultured cells grown under different conditions (see above) were harvested,
washed with Hank’s balanced salt solution (HBSS), and resuspended in
100 ml HBSS containing 0.3 (for cultured Henle-407 or Jurkat cells) or
0.5 mg (for human and chimpanzee primary cells) of Alexa 555-labeled
wild-type or mutant toxin preparations. Cells were incubated in the presence
of the labeled toxin preparations for 15 min on ice and immediately analyzed
by flow cytometry. The binding profiles were analyzed using Flowjo
(Treestar).
Mammalian Cell Intoxication Assay
Cell-cycle arrest after typhoid toxin intoxication was examined by flow cytom-
etry as previously described (Spano` et al., 2008). Briefly, after treatment with
6xHis-tagged typhoid toxin for 66 hr for Henle-407 or 18 hr for Jurkat cells,
cells were trypsinized, collected, washed, and fixed for 2 hr in 70%
ethanol/PBS at 20C. Fixed cells were washed with PBS and resuspended
in 500 ml of PBS containing 50 mg/ml propidium iodide, 0.1 mg/ml RNase A,and 0.05% Triton X-100. After incubation for 40 min at 37C, cells were
washed with PBS, resuspended in 500 ml PBS, filtered, and analyzed by a
flow cytometry. The DNA content of treated cells was determined using Flowjo
program (Treestar).
Mouse Intoxication Experiments
All mouse experiments were conducted according to protocols approved by
Yale University’s Institutional Animal Care and Use Committee. Age- and
sex-matched 5- to 7-week-old C57BL/6 (wild-type), Cmah/ (Jackson Labo-
ratory), or Cmahtg mice were intravenously injected with 100 ml solutions
containing PBS alone, or either 2 mg or 10 mg of the indicated purified toxin
preparations. Changes in behavior, weight, and survival of the toxin-injected
mice were closely monitored and to minimize bias, blind end-point assess-
ment was applied to all the experiments.
Blood Counting
Blood samples were collected by heart puncture 4.5 days after toxin treatment
in Microtainer tubes coated with EDTA as an anticoagulant (BD), kept at room
temperature, and analyzed within 2 hr after blood collection using a Hemavet
950FS hematology analyzer (Drew Scientific). Blood counts were analyzed by
GraphPad Prism (GraphPad Software).Cell 159, 1290–1299, December 4, 2014 ª2014 Elsevier Inc. 1297
Peripheral Blood Cell Preparation, Immunostaining, and Flow
Cytometry Analysis
Peripheral blood samples of typhoid toxin-treated and control mice were
collected into tubes coated with EDTA, incubated with 1 ml ACK buffer
(BioWhittaker), incubated for 5 min, washed with 2 ml PBS, and centrifuged
to collect peripheral blood leukocytes (PBLs). After a repetition of the red
blood cell removal step, PBLs were washed, and were immediately incu-
bated for 30 min on ice with 100 ml of anti-mouse Ly-6G (Gr-1) antibody
conjugated with FITC (eBioscience, 11-5931-81). PBLs were then washed
with 2 ml of FACS buffer (PBS, 0.16% BSA), resuspended in 100 ml FACS
fixation buffer (PBS, 1% paraformaldehyde, 1% FCS), and used for flow
cytometric analyses on BD accuri C6 (BD Biosciences). Peripheral blood
samples from humans and chimpanzees were collected into EDTA tubes.
Erythrocytes were separated from peripheral blood monocytic cells
(PBMC) by Ficoll-Paque Plus. Erythrocytes in the PBMC layer were lysed
by ACK buffer, and monocytes were removed by anti-CD14 beads (MACS
Miltenyi Biotec).
Typhoid Toxin Binding to Human, Chimpanzee, and Mouse Tissues
Cryosections of frozen tissue samples from human, chimpanzee and the
different mouse strains, were overlaid with AF555-labeled wild-type typhoid
toxin or the PltBS35A mutant. After incubation in a covered humid chamber
for 1 hr at room temperature, the slides were washed to remove nonbound
toxins and the sections were fixed using 10% neutral buffered formalin. The
nuclei were counterstained using Hoechst and the slides were washed and
mounted in aqueous mounting media (VectaMount). Digital photomicrographs
were taken using a Keyence BZ9000 fluorescencemicroscope (BIOREVO, BZ-
9000, Keyence).
Statistical Analysis
Two-tailed Student’s t tests were performed in order to determine the statisti-
cal significance of experimental changes from control values. A p value < 0.05
was considered as statistically significant.SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and two tables and can be
found with this article online at http://dx.doi.org/10.1016/j.cell.2014.10.057.
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